The Promise and Limits of Trump's Psychedelic Therapy Order

The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?

What to know about psychedelic retreats, a booming business with few safety guardrails

Surging interest in the purported benefits of psychedelic drugs has given rise to a new industry: psychedelic retreats.

Psychedelic Pharmaceutical Companies' Shares Rise Following Executive Order -- Update

Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of mental illnesses.

What Is Ibogaine? How Psychedelic Could Help Treat Veterans’ Depression

Trump said on Saturday the directive would “dramatically accelerate” access to research and potential treatments.

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today welcomed the White House Executive Order aimed at accelerating research,

FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics

President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.